About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Fatty Liver Disease: When to Refer?
By
Yale School of Medicine
By
Yale School of Medicine
1,720 views
August 19, 2021
3 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
18:46
Houston Methodist Hospital
MAFLD: What Is It?
Feat.
D. Victor
43:23
MedNews Week
Best Practices In Managing NAFLD / NASH
Feat.
D. Bernstein
38:47
UPMC
The Fatty Liver Disease Epidemic
Feat.
M. Klinge
49:14
Scripps Health
Using Resmetirom (THR-β Agonist) in Your Practice for MASH
Feat.
J. Gutierrez
48:59
Northwestern Medicine Gastroenterology
Cutting Edge Diagnostics and Treatment for NAFLD
Feat.
M. E. Rinella,
L. Van Wagner
25:53
Houston Methodist Hospital
Non-Alcoholic Fatty Liver Disease: Where Are We in 2023?
Feat.
N. Gunn
24:30
Scripps Health
Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease
Feat.
J. Au
22:23
Pennsylvania Society of Gastroenterology
Updates on Management of NASH
Feat.
T. Singh
22:31
University of California, Irvine (UCI) Health 14th Annual Orange County Symposium for Cardiovascular Disease Prevention
Non-Alcoholic Fatty Liver Disease and Cardiovascular Risks: A Scient…
Feat.
P. Duell
26:11
Scripps Health
New Treatments of Nonalcoholic Steatohepatitis (NASH): An Update on …
Feat.
J. Frias
31:07
University of Kansas Medical Center
Risk Stratification and Management of Non-Alcoholic Fatty Liver Dise…
Feat.
F. Kanwal
50:07
UChicago Medicine
NAFLD: Updates in Management
Feat.
M. E. Rinella
29:41
UPMC
Update on Metabolic-dysfunction Associated Steatotic Liver Disease
Feat.
T. Woreta
29:18
SC Liver Research Consortium
The Effective Management of Ascites and Hepatorenal Syndrome (HRS)
Feat.
A. Muir
24:38
UCLA Health
Fatty Liver and the Role of Diet
Feat.
M. Tincopa
18:45
Yale School of Medicine
Liver Metabolism: The Evolutionary Basis of Insulin Resistance: Impl…
Feat.
G. Shulman
18:32
UCLA Health
Risk Stratification of Patients with Cirrhosis Undergoing Surgery
Feat.
J. Singh
55:03
University of Colorado Department of Medicine
Liver Transplantation Evaluation
Feat.
A. Kalra
26:46
UCLA Health
Fatty Liver: The Silent Epidemic
Feat.
S. Saab
46:27
University of Colorado Department of Medicine
Non-Alcoholic Steatohepatitis When to Worry and What to Do
Feat.
A. Wieland
